Price Alert

Treace Medical Concepts I... (TMCI)

NASDAQ: TMCI · Real-Time Price · USD

7.01

0.06 (0.86%)

At close: Aug 15, 2025, 12:04 PM

Treace Medical Concepts Statistics

Share Statistics

Treace Medical Concepts has 62.91M shares outstanding. The number of shares has increased by 1.15% in one year.

Shares Outstanding	62.91M
Shares Change (YoY)	1.15%
Shares Change (QoQ)	0.46%
Owned by Institutions (%)	60.47%
Shares Floating	44.8M
Failed to Deliver (FTD) Shares	55
FTD / Avg. Volume	0.02%

Short Selling Information

The latest short interest is 2.74M, so 4.36% of the outstanding shares have been sold short.

Short Interest	2.74M
Short % of Shares Out	4.36%
Short % of Float	5.75%
Short Ratio (days to cover)	10.87

Valuation Ratios

The PE ratio is -8.29 and the forward PE ratio is -8.71. Treace Medical Concepts's PEG ratio is -0.75.

PE Ratio	-8.29
Forward PE	-8.71
PS Ratio	2.21
Forward PS	1.6
PB Ratio	4.09
P/FCF Ratio	-9.48
PEG Ratio	-0.75

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Treace Medical Concepts.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.62.

Current Ratio	4.62
Quick Ratio	3.5
Debt / Equity	0.62
Debt / EBITDA	-1.66
Debt / FCF	-1.43
Interest Coverage	-10.6

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$438.9K
Profits Per Employee	$-116.86K
Employee Count	477
Asset Turnover	0.96
Inventory Turnover	1.05

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by 11.95% in the last 52 weeks. The beta is 0.68, so Treace Medical Concepts's price volatility has been higher than the market average.

Beta	0.68
52-Week Price Change	11.95%
50-Day Moving Average	5.81
200-Day Moving Average	7.3
Relative Strength Index (RSI)	59.05
Average Volume (20 Days)	343,095

Income Statement

In the last 12 months, Treace Medical Concepts had revenue of 209.36M and earned -55.74M in profits. Earnings per share was -0.9.

Revenue	209.36M
Gross Profit	168.26M
Operating Income	-55.69M
Net Income	-55.74M
EBITDA	-42.07M
EBIT	-50.49M
Earnings Per Share (EPS)	-0.9

Full Income Statement

Balance Sheet

The company has 11.35M in cash and 69.65M in debt, giving a net cash position of -58.3M.

Cash & Cash Equivalents	11.35M
Total Debt	69.65M
Net Cash	-58.3M
Retained Earnings	-189.99M
Total Assets	205.85M
Working Capital	116.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -37.17M and capital expenditures -11.59M, giving a free cash flow of -48.76M.

Operating Cash Flow	-37.17M
Capital Expenditures	-11.59M
Free Cash Flow	-48.76M
FCF Per Share	-0.79

Full Cash Flow Statement

Margins

Gross margin is 80.37%, with operating and profit margins of -26.6% and -26.63%.

Gross Margin	80.37%
Operating Margin	-26.6%
Pretax Margin	-26.63%
Profit Margin	-26.63%
EBITDA Margin	-20.09%
EBIT Margin	-26.6%
FCF Margin	-23.29%

Dividends & Yields

TMCI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for TMCI is $7.25, which is 13.8% higher than the current price. The consensus rating is "Hold".

Price Target	$7.25
Price Target Difference	13.8%
Analyst Consensus	Hold
Analyst Count	5

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	1.85
Piotroski F-Score	3